化学療法による睾丸腫瘍の良性転化
スポンサーリンク
概要
- 論文の詳細を見る
Seven patients with disseminated non-seminomatous testicular cancer were treated by surgical removal of metastatic foci, following chemotherapy using a combination of actinomycin-D, methotraxate, cyclophosphamide and vincristine, or a combination of cis-diamminedichloroplatinm, vinblastine and bleomycin. In 2 out of the 7 cases, resected metastatic tissues proved to be mature teratoma. The primary tumors of these 2 cases were embryonal carcinomas and contained no choliomatous elements. The levels of tumor markers (serumce α-fetoprotein and urinary human cholionic gonadotropine) in these 2 cases before surgery fell within a normal range by chemotherapy. The metastatic foci which turned into differentiated tissues (teratoma) were cystic and spongy macroscopically. Microscopically these differentiated tissues were composed of glandular epitherium and smooth muscle cells. In our experiments, cis-diamminedichloroplatinum, vinblastine, and bleomycin in combination was administered to nude mice (BALB/C strain) bearing with human embryonal carcinoma. In some of the semice, tumor cell differention was observed. With regard to the mechanism of tumor maturation, the following can be considered from our experiences. (1) Embryonal carcinomas have to tipotential ability. (2) Totipotential malignant cells can turn into mature teratoma by chemotherapy. (3) Differentiation of totipotential malignant tumors is in fluenced by cell kinetics and biological response.
- 社団法人日本泌尿器科学会の論文
- 1982-07-20
著者
-
町田 豊平
東京慈恵会医科大学泌尿器科学教室
-
町田 豊平
東京慈恵会医科大学
-
増田 富士男
東京慈恵会医科大学
-
赤阪 雄一郎
東京慈恵会医科大学 泌尿器科
-
柳沢 宗利
慈恵医大
-
柳沢 宗利
東京慈恵会医科大学泌尿器科学教室
-
増田 富士男
東京慈恵会医大
関連論文
- 複雑性尿路感染症を対象とする経口用キノロン薬 balofloxacin と ofloxacin の比較試験
- 性感染症としての男子尿道炎におけるAzithromycinの基礎的・臨床的検討
- 複雑性尿路感染症に対するgatifloxacinの用量設定試験
- 泌尿器科領域感染症に対するgatifloxacinの後期第II相臨床試験
- 泌尿器科領域感染症に対するgatifloxacinの前期第II相臨床試験
- 複雑性尿路感染症に対する pazufloxacin と ofloxacin の二重盲検比較試験
- 尿路・***感染症に対するgrepafloxacinの有用性の検討
- 尿路感染症に対するgrepafloxacinの基礎的・臨床的検討
- 表在性膀胱腫瘍に対する Adriamycin 再発予防膀胱腔内注入療法第4次研究(術前注入療法の再発予防効果)結果報告
- 複雑性尿路感染症を対象とする経口用キノロン薬 balofloxacin の至適用量設定試験